Trademark Overview
On Tuesday, July 8, 2025, a trademark application was filed for CELLDX with the United States Patent and Trademark Office. The USPTO has given the CELLDX trademark a serial number of 99271923. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 8, 2025. This trademark is owned by DATAR CANCER GENETICS PRIVATE LIMITED. The CELLDX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical diagnostic testing services, namely, providing in-depth molecular analysis of tumor cells and tumor-derived genetic material for the purposes of assessing tumor burden, detecting genetic alterations, guiding personalized treatment selection, monitoring therapeutic response, and detecting recurrence in cancer patients.
